Penserra Capital Management LLC Assembly Biosciences, Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$2.13 - $3.46 $2,193 - $3,563	-1,030 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$3.14 - $3.9 $361 - $448	115 Added 12.57%	1,030 $3,000
Q2 2021 Aug 12, 2021	BUY	$3.8 - $4.56 $228 - $273	60 Added 7.02%	915 $3,000
Q1 2021 May 13, 2021	BUY	$4.33 - $6.63 $433 - $663	100 Added 13.25%	855 $3,000
Q4 2020 Feb 12, 2021	BUY	$4.87 - $17.29 $2,313 - $8,212	475 Added 169.64%	755 $4,000
Q3 2020 Nov 13, 2020	BUY	$15.08 - $27.04 $4,222 - $7,571	280 New	280 $4,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $765M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.